{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:18:35Z","timestamp":1791159515545,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T00:00:00Z","timestamp":1123027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1038\/sj.npp.1300853","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T15:38:41Z","timestamp":1124984321000},"page":"197-203","source":"Crossref","is-referenced-by-count":17,"title":["Blunted Hormone Responses to Ipsapirone are Associated with Trait Impulsivity in Personality Disorder Patients"],"prefix":"10.1038","volume":"31","author":[{"given":"Michael J","family":"Minzenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia S","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Mitropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Yehuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diedre A","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil F","family":"Coccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J","family":"Siever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,3]]},"reference":[{"key":"BF1300853_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1521\/pedi.18.2.193.32777","volume":"18","author":"CL Battle","year":"2004","unstructured":"Battle CL, Shea MT, Johnson DM, Yen S, Zlotnick C, Zanarini MC et al (2004). Childhood maltreatment associated with adult personality disorders: findings from the Collaborative Longitudinal Personality Disorders Study. J Pers Disord 18: 193\u2013211.","journal-title":"J Pers Disord"},{"key":"BF1300853_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0149-7634(94)90046-9","volume":"18","author":"R Bell","year":"1994","unstructured":"Bell R, Hobson H (1994). 5-HT1A receptor influences on rodent social and agonistic behavior: a review and empirical study. Neurosci Biobehav Rev 18: 325\u2013338.","journal-title":"Neurosci Biobehav Rev"},{"key":"BF1300853_CR3","volume-title":"Childhood Trauma Questionnaire: A Retrospective Self-Report Manual","author":"DP Bernstein","year":"1998","unstructured":"Bernstein DP, Fink L (1998). Childhood Trauma Questionnaire: A Retrospective Self-Report Manual. Psychological Corporation: San Antonio, TX."},{"key":"BF1300853_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/ajp.152.3.437","volume":"152","author":"PM Brett","year":"1995","unstructured":"Brett PM, Curtis D, Robertson MM, Gurling HM (1995). Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Am J Psychiatry 152: 437\u2013440.","journal-title":"Am J Psychiatry"},{"key":"BF1300853_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/h0046900","volume":"21","author":"AH Buss","year":"1957","unstructured":"Buss AH, Durkee A (1957). An inventory for assessing different kinds of hostility. J Consult Psychol 21: 343\u2013349.","journal-title":"J Consult Psychol"},{"key":"BF1300853_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00004850-199801000-00004","volume":"13","author":"AJ Cleare","year":"1998","unstructured":"Cleare AJ, Forsling M, Bond AJ (1998). Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study. Int Clin Psychopharmacol 13: 23\u201332.","journal-title":"Int Clin Psychopharmacol"},{"key":"BF1300853_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s002130050061","volume":"148","author":"AJ Cleare","year":"2000","unstructured":"Cleare AJ, Bond AJ (2000). Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology 148: 344\u2013349.","journal-title":"Psychopharmacology"},{"key":"BF1300853_CR8","first-page":"393","volume":"26","author":"EF Coccaro","year":"1990","unstructured":"Coccaro EF, Gabriel S, Siever LJ (1990). Buspirone challenge: preliminary evidence for a role of 5-HT1A receptors in impulsive aggressive behavior in humans. Psychopharmacol Bull 26: 393\u2013405.","journal-title":"Psychopharmacol Bull"},{"key":"BF1300853_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00004850-199510030-00007","volume":"10","author":"EF Coccaro","year":"1995","unstructured":"Coccaro EF, Kavoussi RJ, Hauger RL (1995). Physiological responses to d-fenfluramine and ipapirone challenge correlate with indices of aggression in males with personality disorder. Int Clin Psychopharmacol 10: 177\u2013179.","journal-title":"Int Clin Psychopharmacol"},{"key":"BF1300853_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0010-440X(98)90050-5","volume":"39","author":"EF Coccaro","year":"1998","unstructured":"Coccaro EF, Kavoussi RJ, Berman ME, Lish JD (1998). Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr Psychiatry 39: 368\u2013376.","journal-title":"Compr Psychiatry"},{"key":"BF1300853_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1034\/j.1399-0004.2000.570304.x","volume":"57","author":"DE Comings","year":"2000","unstructured":"Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H et al (2000). Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57: 178\u2013196.","journal-title":"Clin Genet"},{"key":"BF1300853_CR12","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1097\/00004714-199006001-00005","volume":"10","author":"PJ Cowen","year":"1990","unstructured":"Cowen PJ, Anderson IA, Grahame-Smith DG (1990). Neuroendocrine effects of azapirones. J Clin Psychopharmacol 10: 21S\u201325S.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300853_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02245588","volume":"121","author":"J De Vry","year":"1995","unstructured":"De Vry J (1995). 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl) 121: 1\u201326.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300853_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","volume":"46","author":"WC Drevets","year":"1999","unstructured":"Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ et al (1999). PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375\u20131387.","journal-title":"Biol Psychiatry"},{"key":"BF1300853_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1001\/archpsyc.1990.01810200078011","volume":"47","author":"D Ekstrom","year":"1990","unstructured":"Ekstrom D, Quade D, Golden RN (1990). Statistical analysis of repeated measures in psychiatric research. Arch Gen Psychiatry 47: 770\u2013772.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300853_CR16","volume-title":"User's Guide for the Structured Clinical Interview for DSM-IV Axis I (SCID-I)","author":"MB First","year":"1995","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin LS (1995). User's Guide for the Structured Clinical Interview for DSM-IV Axis I (SCID-I). American Psychiatric Press: Washington, DC."},{"key":"BF1300853_CR17","first-page":"250","volume":"13","author":"R Fuller","year":"1992","unstructured":"Fuller R (1992). The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 13: 250\u2013270.","journal-title":"Front Neuroendocrinol"},{"key":"BF1300853_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0024-3205(03)00422-3","volume":"73","author":"MB Gatch","year":"2003","unstructured":"Gatch MB (2003). Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Life Sci 73: 1347\u20131367.","journal-title":"Life Sci"},{"key":"BF1300853_CR19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF1300853_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1017\/S0033291702005445","volume":"32","author":"M Hansenne","year":"2002","unstructured":"Hansenne M, Pitchot W, Pinto E, Reggers J, Scantamburlo G, Fuchs S et al (2002). 5-HT1A dysfunction in borderline personality disorder. Psychol Med 32: 935\u2013941.","journal-title":"Psychol Med"},{"key":"BF1300853_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0006-3223(01)01157-X","volume":"49","author":"C Heim","year":"2001","unstructured":"Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49: 1023\u20131039.","journal-title":"Biol Psychiatry"},{"key":"BF1300853_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1034\/j.1399-5618.2003.00033.x","volume":"5","author":"J Hennen","year":"2003","unstructured":"Hennen J (2003). Statistical methods for longitudinal research on bipolar disorders. Bipolar Disord 5: 156\u2013168.","journal-title":"Bipolar Disord"},{"key":"BF1300853_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1176\/ajp.151.2.277","volume":"151","author":"E Hollander","year":"1994","unstructured":"Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE et al (1994). Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry 151: 277\u2013280.","journal-title":"Am J Psychiatry"},{"key":"BF1300853_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF02245457","volume":"114","author":"RS Kahn","year":"1994","unstructured":"Kahn RS, Trestman R, Lawlor BA, Gabriel S, Davidson M, Siever L (1994). Effects of ipsapirone in healthy subjects: a dose\u2013response study. Psychopharmacology 114: 155\u2013160.","journal-title":"Psychopharmacology"},{"key":"BF1300853_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0165-1781(02)00250-0","volume":"113","author":"T Klaasen","year":"2002","unstructured":"Klaasen T, Riedel WJ, van Praag HM, Menheere PPCA, Griez E (2002). Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res 113: 29\u201340.","journal-title":"Psychiatry Res"},{"key":"BF1300853_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jpsychires.2004.03.006","volume":"38","author":"HW Koenigsberg","year":"2004","unstructured":"Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R et al (2004). 24-h monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res 38: 503\u2013511.","journal-title":"J Psychiatr Res"},{"key":"BF1300853_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1152\/advan.00042.2003","volume":"28","author":"M Kristensen","year":"2004","unstructured":"Kristensen M, Hansen T (2004). Statistical analyses of repeated measures in physiological research: a tutorial. Adv Physiol Educ 28: 2\u201314.","journal-title":"Adv Physiol Educ"},{"key":"BF1300853_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1006\/bbrc.1996.0322","volume":"219","author":"S Lam","year":"1996","unstructured":"Lam S, Shen Y, Nguyen T, Messier TL, Brann M, Comings D et al (1996). A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient. Biochem Biophys Res Commun 219: 853\u2013858.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1300853_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/070674370104600106","volume":"46","author":"R Lee","year":"2001","unstructured":"Lee R, Coccaro E (2001). The neuropsychopharmacology of criminality and aggression. Can J Psychiatry 46: 35\u201344.","journal-title":"Can J Psychiatry"},{"key":"BF1300853_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0006-3223(89)90024-3","volume":"26","author":"KP Lesch","year":"1989","unstructured":"Lesch KP, Rupprecht R, Poten B, Muller U, Sohnle K, Fritze J et al (1989). Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatry 26: 203\u2013205.","journal-title":"Biol Psychiatry"},{"key":"BF1300853_CR31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1210\/jcem-70-3-670","volume":"70","author":"KP Lesch","year":"1990","unstructured":"Lesch KP, Sohnle K, Poten B, Schoellnhammer G, Rupprecht R, Schulte HM (1990). Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and \u03b2-adrenoceptor antagonists. J Clin Endocrinol Metab 70: 670\u2013674.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1300853_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0278-5846(91)90001-H","volume":"15","author":"KP Lesch","year":"1991","unstructured":"Lesch KP (1991). 5-HT1A receptor responsivity in anxiety disorders and depression. Prog Neuro-Psychopharmacol Biol Psychiatry 15: 723\u2013733.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"BF1300853_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jpsychires.2004.04.002","volume":"38","author":"K Lieb","year":"2004","unstructured":"Lieb K, Rexhausen JE, Kahl KG, Schweiger U, Philipsen A, Hellhammer DH et al (2004). Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res 38: 559\u2013565.","journal-title":"J Psychiatr Res"},{"key":"BF1300853_CR34","first-page":"177","volume-title":"Buspirone: Mechanisms and Clinical Aspects","author":"HY Meltzer","year":"1991","unstructured":"Meltzer HY, Gudelsky GA, Lowy MT, Nash JF, Koenig JI (1991). Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic mechanisms. In: Tunnicliff G, Eison AS, Taylor OP (eds). Buspirone: Mechanisms and Clinical Aspects. Academic Press: San Diego. pp 177\u2013192."},{"key":"BF1300853_CR35","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0006-3223(94)00370-I","volume":"38","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY, Maes M (1995). Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38: 450\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BF1300853_CR36","volume-title":"Borderline Personality Disorder","author":"MJ Minzenberg","year":"2005","unstructured":"Minzenberg MJ, Siever LJ (2005). Biochemical Endophenotypes in Borderline Personality Disorder. In: Zanarini MC (ed). Borderline Personality Disorder. Dekker: New York."},{"key":"BF1300853_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0165-1781(98)00081-X","volume":"81","author":"FG Moeller","year":"1998","unstructured":"Moeller FG, Allen T, Cherek DR, Dougherty DM, Lane S, Swann AC (1998). Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory. Psychiatry Res 81: 31\u201338.","journal-title":"Psychiatry Res"},{"key":"BF1300853_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000119318","volume":"34","author":"P Netter","year":"1996","unstructured":"Netter P, Hennig J, Roed IS (1996). Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology 34: 155\u2013165.","journal-title":"Neuropsychobiology"},{"key":"BF1300853_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-2007-979182","volume":"32","author":"P Netter","year":"1999","unstructured":"Netter P, Hennig J, Rohrmann S (1999). Psychobiological differences between the aggression and psychoticism dimension. Pharmacopsychiatry 32: 5\u201312.","journal-title":"Pharmacopsychiatry"},{"key":"BF1300853_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/archpsyc.59.7.621","volume":"59","author":"AS New","year":"2002","unstructured":"New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V et al (2002). Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 59: 621\u2013629.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300853_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979624","volume":"28S","author":"B Olivier","year":"1995","unstructured":"Olivier B, Mos J, van Oorschot R, Hen R (1995). Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28S: 80\u201390.","journal-title":"Pharmacopsychiatry"},{"key":"BF1300853_CR42","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768\u2013774.","journal-title":"J Clin Psychol"},{"key":"BF1300853_CR43","volume-title":"Structured Interview for DSM-III-R Personality: SIDP-R","author":"BM Pfohl","year":"1989","unstructured":"Pfohl BM, Blum N, Zimmerman M, Stangl D (1989). Structured Interview for DSM-III-R Personality: SIDP-R. Author: Iowa City, IA."},{"key":"BF1300853_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0893-133X(98)00111-0","volume":"20","author":"LJ Siever","year":"1999","unstructured":"Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA et al (1999). d,l-Fenfluramine response in impulsive personality disorder assessed with [18F] flurodeoxyglucose positron emission tomomgraphy. Neuropsychopharmacology 20: 413\u2013423.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300853_CR45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0006-3223(99)00202-4","volume":"47","author":"PH Soloff","year":"2000","unstructured":"Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM (2000). A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47: 540\u2013547.","journal-title":"Biol Psychiatry"},{"key":"BF1300853_CR46","volume-title":"Manual for the State\u2013Trait Anxiety Inventory","author":"CD Spielberger","year":"1983","unstructured":"Spielberger CD, Gorsuch RC, Lushene RE, Vagg PR, Jacobs GA (1983). Manual for the State\u2013Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA."},{"key":"BF1300853_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0165-0327(98)00186-4","volume":"54","author":"LN Yatham","year":"1999","unstructured":"Yatham LN, Shiah IS, Lam RW, Tam EM, Zis AP (1999). Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. J Affect Disord 54: 295\u2013301.","journal-title":"J Affect Disord"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300853","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:49:38Z","timestamp":1684219778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["BF1300853"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300853","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,3]]}}}